ArrePath lands $20m seed
ArrePath, an anti-infective drug discovery company, has raised $20 million in seed financing.
ArrePath, an anti-infective drug discovery company, has raised $20 million in seed financing.
Copyright PEI Media
Not for publication, email or dissemination